Featured Research

from universities, journals, and other organizations

New report outlines growing field of rectal microbicide HIV prevention technology

Date:
May 19, 2010
Source:
International Rectal Microbicide Advocates
Summary:
A new report details the growing scientific activity in the rectal microbicide field, capturing the optimism among researchers and advocates alike as the field sets its sights on the development of safe and effective rectal-specific products that will provide protection against HIV during anal intercourse.

International Rectal Microbicide Advocates (IRMA) will officially release its third landmark report -- "From Promise to Product: Advancing Rectal Microbicide Research and Advocacy" -- at the 2010 International Microbicides Conference in Pittsburgh, PA taking place May 22-25, 2010.

The ambitious, comprehensive document reports on the growing scientific activity in the rectal microbicide field, capturing the optimism among researchers and advocates alike as the field sets its sights on the development of safe and effective rectal-specific products that will provide protection against HIV during anal intercourse.

Additionally, IRMA continues to call for a Global Rectal Microbicide Development plan by which stakeholders can coordinate efforts across the full range of scientific activities, developing strategies and setting priorities. Such a plan does not yet exist.

Dr. Ian McGowan, Scientific Vice-Chair on the IRMA Steering Committee and co-Principal Investigator of the Microbicide Trials Network says, "A detailed map such as a Global Rectal Microbicide Development Plan is absolutely necessary if we are going to make the best use of each and every research dollar in this time of global recession and constricted resources."

An updated resource tracking of funds specifically allocated to rectal microbicide research and development -- the only such exercise -- is followed by a call for escalating funding over the next 10 years and for increased diversity in the funding portfolio as well. The United States National Institutes of Health currently provides over 90% of global resources devoted to rectal microbicide activities, and nations of the European Union and global philanthropic organizations need to support this critical work as well.

"Increased funding is also needed for IRMA. We maintain an enormous global footprint and are the only advocacy group focused on rectal microbicides in the world -- and we achieve this with inadequate resources," says IRMA Chair and Director of Advocacy for the AIDS Foundation of Chicago Jim Pickett. "Our work must be valued and supported if we are to continue uniting AIDS advocates, scientists, and policy makers around the globe to bring safe and effective rectal microbicides to market as well as to confront the homophobia, gender inequities, human rights, stigma, and denial that must be addressed to make sure such products will be used."

The full report is available online in both English and Spanish. Visit http://rectalmicrobicides.org/materials.php


Story Source:

The above story is based on materials provided by International Rectal Microbicide Advocates. Note: Materials may be edited for content and length.


Cite This Page:

International Rectal Microbicide Advocates. "New report outlines growing field of rectal microbicide HIV prevention technology." ScienceDaily. ScienceDaily, 19 May 2010. <www.sciencedaily.com/releases/2010/05/100519131122.htm>.
International Rectal Microbicide Advocates. (2010, May 19). New report outlines growing field of rectal microbicide HIV prevention technology. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2010/05/100519131122.htm
International Rectal Microbicide Advocates. "New report outlines growing field of rectal microbicide HIV prevention technology." ScienceDaily. www.sciencedaily.com/releases/2010/05/100519131122.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins